Legend Capital Celebrates 40 Portfolio Companies and Individuals Recognized in the '2026 Future Healthcare 100' Awards
Ribo Life Science
Small Nucleic Acid Drug Developer
Harbour BioMed
Antibody Drug Developer
WuXi AppTec
New Drug R&D and Production Service Provider
Recently, the highly anticipated “2026 Future Healthcare Top 100” gala was grandly held,Legend Capital and 40 of Its Healthcare Portfolio Companies and Individuals Honored on the List。
As the benchmark for innovation evaluation in China’s healthcare industry, the “Future Healthcare Top 100” has, over the past decade, profoundly witnessed and participated in the growth and upgrading of China’s medical innovation ecosystem. The 2026 selection is anchored by the theme “Global Investment Value Trends,” focusing on pioneering entities that drive the efficient circulation of innovative assets and facilitate the realization of “China-first” achievements.
It is reported that “Top 100 Future Healthcare Companies 2026”SelectionDriven by multiple shifts in the industry landscape and innovation paradigms, and oriented toward the “showcasing, trading, and empowerment of innovative healthcare assets in China,” the selection process has received over 1,000 applications since its launch in December 2025. Each submission embodies a passion for innovation and consolidates the upward momentum of the industry.
Below are the details of Legend Capital’s portfolio companies that received awards:
List of Innovative Medical Devices and Intelligent Manufacturing
TOP100
Core Medical
Zhiran Medical
NanoVision
Shenluo Medical
Vizor Zhiyuan
Golden Key Medicine
Caike Biotech
Dingke Medical
Tongxin Zhiyi
Ruilapu Medical
Fengkaili
StarSea Medical
List of Innovative Pharmaceuticals and Biological Products
TOP100
Haihe Pharmaceuticals
Xianweida Biologics
ImmuneOnco Biopharmaceuticals
Link Therapeutics
StoneWise Intelligence
Huajian Future
Zhongsheng Suyuan
X-Unknown
Qingpu Bio
Lingtaike Biotech
List of Innovative Health Services and Industrial Chain Services
TOP100
Yeasen Biotechnology
GeneCopoeia
Gerui Technology
Beianji
Juyi Technology
Ailiuos
2026 China Healthcare Industry
Top 50 Most Investment-Worthy Companies
- Listed Company -
Ribo Life Science
-Non-listed Company-
Haihe Pharmaceuticals
Topview Medical
Zhiran Medical
China's Healthcare Industry in 2026
Top 50 Most Innovative Product Technologies
-Intelligent Medical Device Technology-
AOHUA Endoscopy
Fengkaili
Shenluo Medical
Xiran Medical
-Biotechnology-
Fengxun Biotech
Shenxin Bio
Zhongsheng Suyuan
Top 50 Innovative Listed Healthcare Companies in China
Harbour BioMed (02142.HK)
Aidite (301580.SZ)
Innovent Biologics (01801.HK)
Top 50 Chinese Listed Healthcare Companies Going Global
WuXi AppTec (603259.SH/02359.HK)
WuXi Biologics (02269.HK)
Pharmaron (300759.SZ/03759.HK)
Impact Entrepreneur
Founder, Chairman and CEO of Harbour BioMed
Wang Jinsong
Impact Investor
Managing Director, Legend Capital
Hong Tan
Further Reading
1
Legend Capital’s 13 Portfolio Companies Recognized as Shanghai Innovative Enterprise Headquarters
2
Legend Capital Wins Top 1 Award in the “Real Cash Exit Ranking” of Venture Capital Firms for 2025 by LP Advisors
3
Legend Capital Wins Multiple Awards, Including “Top 4 Chinese Venture Capital Firms of 2025” by Rongzhong
4
Legend Capital Wins Multiple Prestigious Awards, Including Zero2IPO’s “Top 5 Venture Capital Firms in China for 2025”
5
Nearly 50 Portfolio Companies of Legend Capital Selected for the 2025 “GEI China Potential Unicorn Enterprise List”
